LENZ Therapeutics (LENZ) is aware of a recent adverse event report submitted to the U.S. Food and Drug Administration’s Adverse Event Reporting System database describing a retinal tear in a patient ...
TipRanks on MSN
Lenz drops nearly 30% after FDA’s FAERS finds retinal tear
Shares of Lenz Therapeutics (LENZ) dropped after a case of retinal tear surfaced inn the FDA’s adverse-event database known as FAERS. The company, ...
Investing.com -- LENZ Therapeutics (NASDAQ:LENZ) stock tumbled 25% on heavy volume Friday in New York after a case of retinal tear associated with its VIZZ eye drop appeared in the FDA’s adverse event ...
When vision deteriorates, it's easy to dismiss it as just 'getting older.' However, it could be a sign of retinal disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback